A look at some of the exciting drugs that could be approved in the coming months.
Monoclonal antibody for autoimmune and neurodegenerative disorders.
Current phase 3 studies investigative novel, preventative approaches.
Exciting and upcoming developments, years in the making.
The vaccines that could make a big impact on healthcare, from radical new flu vaccines to simplified meningococcal vaccine regimens.
Approved and upcoming drugs to look forward to this year.
Specialty pharmaceuticals make up a significant part of the current drug market, and their impact is only going to grow over the next few years.